When:
June 8, 2021 @ 1:00 pm – 2:00 pm
America/New York Timezone
2021-06-08T13:00:00-04:00
2021-06-08T14:00:00-04:00
Where:
Webinar
Contact:
CCM lesions develop when blood vessel cells (endothelial cells) lose the function for one of the CCM genes. New research shows us that, for those lesions that are actively growing and causing symptoms, the endothelial cells also have acquired mutations in a common cancer-causing gene called PIK3CA. This discovery adds to the body of knowledge related to CCM biology and identifies a new target for treatment and a possible class of medicine. Dr. Kahn and Dr. Marchuk discuss their research and findings.
This is the first of a 2-part series on this topic. On June 16th, Dr. Issam Awad will share information about rapamycin as well as offer updates on the atorvastatin trial, biomarkers, and COVID.
